Growth Metrics

Vanda Pharmaceuticals (VNDA) EBITDA Margin Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -40,178.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 530.00
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -932.00
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 7,003.00
10 Vanda Pharmaceuticals 379.35 Mn 177.04 Mn 48.56 Mn -10,026.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -10,026.00
Dec 31, 2025 -8,069.00
Sep 30, 2025 -6,151.00
Jun 30, 2025 -7,856.00
Mar 31, 2025 -6,932.00
Dec 31, 2024 -3,208.00
Sep 30, 2024 -3,855.00
Jun 30, 2024 -3,840.00
Mar 31, 2024 -3,608.00
Dec 31, 2023 -3,119.00
Sep 30, 2023 -2,835.00
Jun 30, 2023 -2,103.00
Mar 31, 2023 328.00
Dec 31, 2022 311.00
Sep 30, 2022 -1,223.00
Jun 30, 2022 -1,147.00
Mar 31, 2022 -853.00
Dec 31, 2021 -471.00
Sep 30, 2021 252.00
Jun 30, 2021 970.00
Mar 31, 2021 1,065.00
Dec 31, 2020 2,014.00
Sep 30, 2020 2,450.00
Jun 30, 2020 1,987.00
Mar 31, 2020 2,152.00
Dec 31, 2019 929.00
Sep 30, 2019 2,037.00
Jun 30, 2019 3,062.00
Mar 31, 2019 3,383.00
Dec 31, 2018 6,471.00
Sep 30, 2018 4,706.00
Jun 30, 2018 2,881.00
Mar 31, 2018 5,287.00
Dec 31, 2017 -45,760.00
Sep 30, 2017 -129.00
Jun 30, 2017 19,434.00
Mar 31, 2017 26,956.00
Dec 31, 2016 8,700.00
Sep 30, 2016 6,066.00
Jun 30, 2016 2,773.00
Mar 31, 2016 1,908.00
Dec 31, 2015 3,440.00
Sep 30, 2015 3,143.00
Jun 30, 2015 7,671.00
Mar 31, 2015 5,569.00
Dec 31, 2014 52,402.00
Sep 30, 2014 3,153.00
Jun 30, 2014 -17,855.00
Mar 31, 2014 -29,079.00
Dec 31, 2013 -7,223.00
Sep 30, 2013 -7,261.00
Jun 30, 2013 -11,606.00